Skip to main content

Merck news and events in 2026

Merck is a multinational biopharmaceutical organization that researches and develops health solutions. The organization focuses on the creation of vaccines, cancer treatments, and animal health products.

Public (MRK)Pharmaceutical Manufacturing10,000+ employeesmerck.comLinkedIn

Get Merck's live signals in Claude or ChatGPT, or by API

AskWhat changed at Merck this week? Use Autobound signals for merck.com.
Dated updates
95
Last event
Nov 17, 2026
Open rolesSnapshot Nov 17, 2026
211
Latest SEC filing
Nov 4, 2026

Source: Autobound Signal API · 95 signals tracked for Merck · updated

Overview

Merck by topic

Latest events

Latest Merck events

  1. In development
    Merck & Co. stock advances as COPD trial opens new catalyst pathMerck & Co. has initiated ENHANCE-3, a Phase 3 clinical trial evaluating OHTUVAYRE (ensifentrine) for the prevention of COPD exacerbations.
  2. Revenue
    Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strengthMerck reported third-quarter revenue of $18.09 billion, up 5% year-over-year.
  3. Acquisition
    Merck to Acquire Silence Therapeutics for $1.3 Billion, Expanding Rare Disease Portfolio with siRNA InnovationMerck entered into a definitive agreement to acquire Silence Therapeutics for approximately $1.3 billion in equity value.
  4. Facility expansion
    Merck Commits $2.9 Billion to Montgomery County ExpansionMerck plans to invest $2.9 billion to expand its pharmaceutical research and manufacturing operations in Montgomery County by the end of 2030.
  5. Facility expansion
    Merck unveils $500M research building at West Point campus in Montgomery CountyMerck is investing $50 million in its research and development facilities at Spring House Innovation Park in Lower Gwynedd, Pennsylvania.
  6. Facility expansion
    Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to makeMerck officially opened a new 120,000-square-foot research and development facility named Advance on its West Point, Pennsylvania campus.
  7. Executive hire
    Paul J. Diaz Elected to Merck BoardPaul J. Diaz, Member of the Board of Directors
  8. In development
  9. In development
    Merck reports trial results. Scotiabank raises target for Merck stockMerck & Co. reported positive phase 2b trial results for its drug candidate tulisokibart, with the high-dose group achieving a 72% response rate compared to 35% for placebo.
  10. In development

Showing 10 of 29 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Merck with the Signal API

One POST /v1/companies/enrich call with merck.com returns every signal type for Merck, each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"merck.com","limit":20}'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Merck questions

What is the latest news on Merck?
On Nov 3, 2026, ad-hoc-news.de reported: Merck & Co. stock advances as COPD trial opens new catalyst path. This page tracks 29 news events for Merck since Jun 10, 2026, each with a date and a source link.
What is going on with Merck?
In the 90 days to Nov 19, 2026, Autobound tracked 14 news events, 1 10-Q filing, 2 8-K filings, 4 hiring snapshots, 1 reported layoff round, 1 deal, 1 executive move, 52 signals for Merck. The newest story is from Nov 3, 2026 (In development), reported by ad-hoc-news.de.
Is Merck laying off employees?
latestly.com reported on Sep 4, 2026: Merck Layoffs: 54 Positions Cut at New Jersey Facility as Part of USD 3 Billion Savings Plan. Autobound lists 1 reported layoff round for Merck. Each row states what its source reported, not a confirmed total.
Has Merck announced any acquisitions?
The latest deal story is from Oct 26, 2026. biopharmaapac.com reported: Merck to Acquire Silence Therapeutics for $1.3 Billion, Expanding Rare Disease Portfolio with siRNA Innovation. The acquisitions page lists 2 deals with a source for each.
What else does Autobound track for Merck?
Beyond news and filings, Autobound lists 58+ signals for Merck from 6 sources: Glassdoor (15+), Website changes (15+), X (Twitter) (13), Reddit (10), Patents (3), Podcasts (2). See the Merck signals page for the dated list.
Is Merck hiring right now?
Yes. As of Nov 17, 2026, Merck had 211 open roles, and Research and development had the most with 30.

Page updated , the date of the newest row on this page.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →